Menstrual hemocidin HbB115-146 is an acidophilic antibacterial peptide potentiating the activity of human defensins, cathelicidin and lysozyme.
OBJECTIVE
Our recent studies proved that menstrual discharge is exceptionally rich in bactericidal hemoglobin peptides (hemocidins). Of special interest is the behavior of hemocidins in low pH of the vagina, in different ionic strengths, and in the presence of other specialized antibacterial molecules acting in this organ.


METHODS
We studied the activity of a model representative of menstrual hemocidin: the peptide from human beta-globin, spanning residues 115-146 (HbB115-146). The bactericidal action of this peptide in different physicochemical conditions, as well as the evaluation of the synergistic effect of the peptide with mixtures of neutrophil alpha-defensin HNP-1, epithelial beta-defensin HBD-1, cathelicidin LL-37 and lysozyme were studied using the bacterial membrane permeability test.


RESULTS
The HbB115-146 is a salt-resistant antibiotic molecule strongly potentiating its activity in acidic conditions (pH 4.4-5.0), characteristic for the vagina. Hemocidin HbB115-146 is also an effective factor stimulating the activity of other antibacterial polypeptides present in the female urogenital tract. The observed synergistic effect is preserved or enhanced at lower pH and, with the exception of HBD-1, is observed also at physiological salt concentrations.


CONCLUSIONS
The results of this study clearly demonstrate that hemocidins are important polypeptide factors involved in maintaining vaginal immunity during normal menstrual bleedings.
Mak
Pawel
P
Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland. makp@mol.uj.edu.pl
Siwek
Michal
M
Pohl
Jan
J
Dubin
Adam
A
D000143:Acids / Q000737:chemistry; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides / Q000378:metabolism*; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D023082:Defensins / Q000378:metabolism*; D004926:Escherichia coli / Q000187:drug effects; D005914:Globins / Q000494:pharmacology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008597:Menstrual Cycle; D008954:Models, Biological; D009113:Muramidase / Q000378:metabolism*; D010446:Peptide Fragments / Q000737:chemistry / Q000494:pharmacology*; D054804:Cathelicidins
D000143:Acids; D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D023082:Defensins; D010446:Peptide Fragments; D005914:Globins; D009113:Muramidase; D054804:Cathelicidins